CRIS Current Research Information System

BROCCHI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.271
AS - Asia 2.091
EU - Europa 1.659
AF - Africa 212
SA - Sud America 93
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.235
SG - Singapore 684
CN - Cina 552
VN - Vietnam 428
IT - Italia 392
SE - Svezia 251
DE - Germania 246
GB - Regno Unito 246
HK - Hong Kong 168
IN - India 119
IE - Irlanda 86
RU - Federazione Russa 84
NL - Olanda 82
BR - Brasile 70
FR - Francia 67
TG - Togo 61
KR - Corea 47
CI - Costa d'Avorio 45
FI - Finlandia 44
SC - Seychelles 38
CH - Svizzera 36
NG - Nigeria 33
JO - Giordania 29
BG - Bulgaria 26
UA - Ucraina 25
ZA - Sudafrica 25
CA - Canada 23
BE - Belgio 16
JP - Giappone 16
ES - Italia 14
BD - Bangladesh 11
EE - Estonia 11
ID - Indonesia 11
MX - Messico 11
AT - Austria 10
AR - Argentina 9
PL - Polonia 6
EC - Ecuador 4
GR - Grecia 4
HR - Croazia 4
TH - Thailandia 4
CO - Colombia 3
EG - Egitto 3
PK - Pakistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
TR - Turchia 3
AL - Albania 2
AU - Australia 2
BS - Bahamas 2
CL - Cile 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
PY - Paraguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
ET - Etiopia 1
GM - Gambi 1
IQ - Iraq 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
NR - Nauru 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
Totale 6.330
Salva come PNG Salva come JPEG
Città #
Singapore 516
Ashburn 329
Chandler 250
Southend 207
Hong Kong 164
Fairfield 161
Santa Clara 115
Hefei 109
Bologna 108
Beijing 90
Dublin 86
Ho Chi Minh City 84
Princeton 82
Seattle 77
Houston 76
Wilmington 73
Dallas 72
Dong Ket 70
Woodbridge 66
Hanoi 65
Lomé 61
Cambridge 54
Boardman 52
Seoul 46
Abidjan 45
Ann Arbor 41
Munich 34
Los Angeles 33
Bern 32
New York 32
Abeokuta 30
Helsinki 30
Amman 29
Redondo Beach 26
Sofia 26
Berlin 25
Turin 24
Westminster 23
Buffalo 21
Bremen 20
Redmond 20
Falkenstein 19
Nanjing 19
Florence 17
Des Moines 16
Saint Petersburg 16
Brussels 15
Haiphong 14
San Diego 14
Jinan 13
Milan 13
Rome 13
Medford 12
Shenyang 12
Toronto 12
Tokyo 11
Bengaluru 10
Chicago 10
Frankfurt am Main 10
London 10
São Paulo 10
Amsterdam 9
Changsha 9
Da Nang 9
Guangzhou 9
Jakarta 9
Delhi 8
Hyderabad 8
Lappeenranta 8
Redwood City 8
Shanghai 8
Yubileyny 8
Bühl 7
Modena 7
Zhengzhou 7
Boston 6
Bắc Giang 6
Haikou 6
Hebei 6
Nuremberg 6
Parma 6
Phoenix 6
Pune 6
San Francisco 6
Tianjin 6
Tongling 6
Turku 6
Vũng Tàu 6
Biên Hòa 5
Chengdu 5
Chongqing 5
Falls Church 5
Jacksonville 5
Nanchang 5
Ninh Bình 5
Padova 5
Paris 5
Quận Bình Thạnh 5
Salt Lake City 5
Solarolo 5
Totale 4.022
Salva come PNG Salva come JPEG
Nome #
An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI alone 255
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC 235
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver 215
Optimization of pineapple juice amount used as a negative oral contrast agent in magnetic resonance cholangiopancreatography 183
Comparison between contrast enhanced MRI and FDG PET/TC in the staging, treatment and follow-up of multiple myeloma. 177
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 177
Correlation Between Renal Cortical Stiffness and Histological Determinants by Point Shear-Wave Elastography in Patients With Kidney Transplantation 173
Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding 172
Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib 164
Complete Recalcification Following Arterial Embolization of Massive Osteolytic Bone Metastasis From NSCLC 155
New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: A new diagnostic algorithm 153
Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins 149
Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case report. 145
A New Quantitative Classification of the Extrahepatic Biliary Tract Related to Cystic Duct Implantation 144
Imaging of colorectal liver metastases: New developments and pending issues 143
null 142
Multiparametric Whole-Body MRI: A Game Changer in Metastatic Prostate Cancer 139
Distinguishing between immune-related pneumonitis and disease progression in advanced Non Small Cell Lung Cancer treated with PD-1 inhibitors: Can serum tumour markers have a role? 136
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations 135
A step towards a multidisciplinary interpretative algorithm for indeterminate adrenal lesions: the value of visual and semi-quantitative 18F-FDG PET/CT and ceCT parameters 133
Conservative treatment and radiological follow-up in a case of pneumatosis intestinalis associated with enteral tube feeding 131
SP714SHEAR WAVE ELASTOGRAPHY IN KIDNEY TRANSPLANTATION: NONINVASIVE ALTERNATIVE TO ALLOGRAFT BIOPSY? 130
Contrast-Enhanced MRI and FDG PET/TC in the assessment of Multiple Myeloma: a comparison of results in different phases of the disease. 129
Ruolo della biopsia PET/TC guidata 127
New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event 127
Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma 123
Differences between FDG PET-TC and contrast enhanced MRI in the staging of patients affected by multiple myeloma. 123
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors 123
New MRI series for kidney evaluation: Saving time and money 117
Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report 113
LI-RADS: a great opportunity not to be missed 112
Gastric cancer staging: Is it time for magnetic resonance imaging? 112
Expected and non-expected immune-related adverse events detectable by CT 110
Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification 108
Preoperative computed tomography assessment for a deep inferior epigastric perforator (DIEP) flap: a new easy technique from the Bologna experience 106
Tumor growth rate decline despite progressive disease may predict improved nivolumab treatment outcome in mrcc: When recist is not enough 102
Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma? 101
Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (Hcc) with orbital metastases: A case report 100
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: A case series 99
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) 97
Pseudolesions in cirrhotic liver 96
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma 95
PET/CT guided biopsy in lymphoma patients 92
Trapianto di fegato 91
Association between anatomic variations of extrahepatic and intrahepatic bile ducts: Do look up! 90
Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications 89
Prognostic value of integrated morphofunctional imaging methods in inoperable intrahepatic cholangiocarcinoma 70
Renal allograft shearwave elastography: a new diagnostic tool to assess chronic allograft alterations compared with biopsy 62
Actionable imaging findings in the daily PET/CT scenario 57
Transient asymptomatic pulmonary opacities and interstitial lung disease in EGFR-mutated non-small cell lung cancer treated with osimertinib 57
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (British Journal of Cancer, (2020), 123, 1, (26-32), 10.1038/s41416-020-0845-3) 44
A New Quantitative Classification of the Extrahepatic Biliary Tract Related to Cystic Duct Implantation 38
Totale 6.496
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.463
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021404 0 0 0 0 0 18 22 36 67 33 26 202
2021/2022841 30 19 60 42 78 39 14 78 44 54 245 138
2022/20231.136 74 185 56 146 82 98 28 69 201 27 94 76
2023/2024370 29 58 29 30 25 85 13 24 13 31 23 10
2024/20251.356 86 153 109 106 178 74 90 57 26 121 83 273
2025/20261.614 335 405 264 231 351 28 0 0 0 0 0 0
Totale 6.496